Inferior Vena Cava Filters in the Management of Venous Thromboembolism - Reply

Tobias Tritschler; Noémie Kraaijpoel; Philip S. Wells

doi:10.1001/jama.2018.21127

Inferior Vena Cava Filters in the Management of Venous Thromboembolism - Reply

Tobias Tritschler
, Noémie Kraaijpoel
, Philip S. Wells

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1007
Number of pages	1
Journal	JAMA - Journal of the American Medical Association
Volume	321
Issue number	10
DOIs	https://doi.org/10.1001/jama.2018.21127
State	Published - 12 Mar 2019
Externally published	Yes

Access to Document

10.1001/jama.2018.21127

Cite this

@article{ea278a3a20364db5b10fadd346b8c8b9,

title = "Inferior Vena Cava Filters in the Management of Venous Thromboembolism - Reply",

author = "Tobias Tritschler and No{\'e}mie Kraaijpoel and Wells, \{Philip S.\}",

note = "Funding Information: Author Affiliations: Division of Hematology, Ottawa Hospital, Ottawa, Ontario, Canada (Tritschler); Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands (Kraaijpoel); Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada (Wells). Corresponding Author: Philip S. Wells, MD, FRCP(C), MSc, 501 Smyth Rd, PO Box 206, Ottawa, ON K1H 8L6, Canada ([email protected]). Conflict of Interest Disclosures: Dr Tritschler reported receiving a grant from the Swiss National Science Foundation and nonfinancial support from Pfizer. Dr Wells reported receiving honoraria for advisory board meetings from Bayer Healthcare, Sanofi, and Daiichi Sankyo and research funding from Bristol-Myers Squibb/Pfizer. No other disclosures were reported. 1. Tritschler T, Kraaijpoel N, Le Gal G, Wells PS. Venous thromboembolism: advances in diagnosis and treatment. JAMA. 2018;320(15):1583-1594. doi:10. 1001/jama.2018.14346 2. Decousus H, Leizorovicz A, Parent F, et al; Pr{\'e}vention du Risque d{\textquoteright}Embolie Pulmonaire par Interruption Cave Study Group. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med. 1998;338(7):409-415. doi:10.1056/ NEJM199802123380701 3. Mismetti P, Laporte S, Pellerin O, et al; PREPIC2 Study Group. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial. JAMA. 2015;313(16):1627-1635. doi:10.1001/jama.2015.3780 4. PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d{\textquoteright}Embolie Pulmonaire par Interruption Cave) randomized study. Circulation. 2005;112(3):416-422. doi:10.1161/CIRCULATIONAHA.104.512834 5. Geerts W, Selby R. Inferior vena cava filter use and patient safety: legacy or science? Hematology Am Soc Hematol Educ Program. 2017;2017(1):686-692. 6. Reddy S, Lakhter V, Zack CJ, Zhao H, Chatterjee S, Bashir R. Association between contemporary trends in inferior vena cava filter placement and the 2010 US Food and Drug Administration advisory. JAMA Intern Med. 2017;177(9): 1373-1374. doi:10.1001/jamainternmed.2017.2719",

year = "2019",

month = mar,

day = "12",

doi = "10.1001/jama.2018.21127",

language = "English",

volume = "321",

pages = "1007",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "10",

}

TY - JOUR

T1 - Inferior Vena Cava Filters in the Management of Venous Thromboembolism - Reply

AU - Tritschler, Tobias

AU - Kraaijpoel, Noémie

AU - Wells, Philip S.

N1 - Funding Information: Author Affiliations: Division of Hematology, Ottawa Hospital, Ottawa, Ontario, Canada (Tritschler); Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands (Kraaijpoel); Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada (Wells). Corresponding Author: Philip S. Wells, MD, FRCP(C), MSc, 501 Smyth Rd, PO Box 206, Ottawa, ON K1H 8L6, Canada ([email protected]). Conflict of Interest Disclosures: Dr Tritschler reported receiving a grant from the Swiss National Science Foundation and nonfinancial support from Pfizer. Dr Wells reported receiving honoraria for advisory board meetings from Bayer Healthcare, Sanofi, and Daiichi Sankyo and research funding from Bristol-Myers Squibb/Pfizer. No other disclosures were reported. 1. Tritschler T, Kraaijpoel N, Le Gal G, Wells PS. Venous thromboembolism: advances in diagnosis and treatment. JAMA. 2018;320(15):1583-1594. doi:10. 1001/jama.2018.14346 2. Decousus H, Leizorovicz A, Parent F, et al; Prévention du Risque d’Embolie Pulmonaire par Interruption Cave Study Group. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med. 1998;338(7):409-415. doi:10.1056/ NEJM199802123380701 3. Mismetti P, Laporte S, Pellerin O, et al; PREPIC2 Study Group. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial. JAMA. 2015;313(16):1627-1635. doi:10.1001/jama.2015.3780 4. PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d’Embolie Pulmonaire par Interruption Cave) randomized study. Circulation. 2005;112(3):416-422. doi:10.1161/CIRCULATIONAHA.104.512834 5. Geerts W, Selby R. Inferior vena cava filter use and patient safety: legacy or science? Hematology Am Soc Hematol Educ Program. 2017;2017(1):686-692. 6. Reddy S, Lakhter V, Zack CJ, Zhao H, Chatterjee S, Bashir R. Association between contemporary trends in inferior vena cava filter placement and the 2010 US Food and Drug Administration advisory. JAMA Intern Med. 2017;177(9): 1373-1374. doi:10.1001/jamainternmed.2017.2719

PY - 2019/3/12

Y1 - 2019/3/12

UR - https://www.scopus.com/pages/publications/85062733840

U2 - 10.1001/jama.2018.21127

DO - 10.1001/jama.2018.21127

M3 - Letter

C2 - 30860557

AN - SCOPUS:85062733840

SN - 0098-7484

VL - 321

SP - 1007

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

IS - 10

ER -